Southwest Research Institute (SwRI) has demonstrated a new application for its cell-expansion bioreactor to advance tissue engineering and cell-based therapies for treatment of injuries and diseases.
Biopharmaceutical companies don’t have to stick to a single bioreactor design during scale-up. That’s according to Stefan Junne, PhD, an associate professor at Aalborg University. Junne, who will be ...
New Gibco™ CTS™ DynaXS™ Single Use Bioreactor supports flexible, cGMP-ready cell expansion from process development to clinical production to support the development of cell therapies for cancer, ...
The practice of integrating bags, tubing, and filters into preassembled, ready-to-use bioprocess solutions is optimized if noninvasive sensing of critical process parameters is part of the package.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results